These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33229692)

  • 1. Excimer laser phototherapeutic keratectomy with mitomycin C application to treat haze after myopic photorefractive keratectomy.
    Sudanaboina P; Murthy SI; Rathi VM
    Indian J Ophthalmol; 2020 Dec; 68(12):3030-3031. PubMed ID: 33229692
    [No Abstract]   [Full Text] [Related]  

  • 2. Mitomycin C in photorefractive keratectomy.
    Shalaby A; Kaye GB; Gimbel HV
    J Refract Surg; 2009 Jan; 25(1 Suppl):S93-7. PubMed ID: 19248535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corneal Breakthrough Haze After Photorefractive Keratectomy With Mitomycin C: Incidence and Risk Factors.
    Kaiserman I; Sadi N; Mimouni M; Sela T; Munzer G; Levartovsky S
    Cornea; 2017 Aug; 36(8):961-966. PubMed ID: 28542088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phototherapeutic keratectomy with mitomycin C for corneal haze following photorefractive keratectomy for myopia.
    Porges Y; Ben-Haim O; Hirsh A; Levinger S
    J Refract Surg; 2003; 19(1):40-3. PubMed ID: 12553604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visually significant haze after retreatment with photorefractive keratectomy with mitomycin-C following laser in situ keratomileusis.
    Liu A; Manche EE
    J Cataract Refract Surg; 2010 Sep; 36(9):1599-601. PubMed ID: 20692575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized dose-response analysis of mitomycin-C to prevent haze after photorefractive keratectomy for high myopia.
    Hofmeister EM; Bishop FM; Kaupp SE; Schallhorn SC
    J Cataract Refract Surg; 2013 Sep; 39(9):1358-65. PubMed ID: 23830559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Astigmatism: risk factor for postoperative corneal haze in conventional myopic photorefractive keratectomy.
    Thomas KE; Brunstetter T; Rogers S; Sheridan MV
    J Cataract Refract Surg; 2008 Dec; 34(12):2068-72. PubMed ID: 19027561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced application time for prophylactic mitomycin C in photorefractive keratectomy.
    Virasch VV; Majmudar PA; Epstein RJ; Vaidya NS; Dennis RF
    Ophthalmology; 2010 May; 117(5):885-9. PubMed ID: 20163867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitomycin C application after photorefractive keratectomy in high, moderate, or low myopia: Systematic review and meta-analysis.
    Ouerdane Y; Zaazouee MS; Mohamed MEA; Hasan MT; Hamdy M; Ghoneim AM; Gbreel MI; Ibrahim AM; Ragab KM; Nourelden AZ
    Indian J Ophthalmol; 2021 Dec; 69(12):3421-3431. PubMed ID: 34826969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-time mitomycin-C application during photorefractive keratectomy in patients with low myopia.
    Shojaei A; Ramezanzadeh M; Soleyman-Jahi S; Almasi-Nasrabadi M; Rezazadeh P; Eslani M
    J Cataract Refract Surg; 2013 Feb; 39(2):197-203. PubMed ID: 23183351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed epithelial healing following photorefractive keratectomy with mitomycin C treatment.
    Kremer I; Ehrenberg M; Levinger S
    Acta Ophthalmol; 2012 May; 90(3):271-6. PubMed ID: 20456254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitomycin C reduces haze formation in rabbits after excimer laser photorefractive keratectomy.
    Xu H; Liu S; Xia X; Huang P; Wang P; Wu X
    J Refract Surg; 2001; 17(3):342-9. PubMed ID: 11383766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Very late-onset corneal scar triggered by trauma after photorefractive keratectomy.
    Gomes BA; Smadja D; Espana EM; Ahn ES; Netto MV; Santhiago MR
    J Cataract Refract Surg; 2012 Sep; 38(9):1694-7. PubMed ID: 22906452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitomycin-C in photorefractive keratectomy.
    Leccisotti A; Fields SV
    J Cataract Refract Surg; 2014 Mar; 40(3):508. PubMed ID: 24581785
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of mitomycin-C on the variance in refractive outcomes after photorefractive keratectomy.
    Sy ME; Zhang L; Yeroushalmi A; Huang D; Hamilton DR
    J Cataract Refract Surg; 2014 Dec; 40(12):1980-4. PubMed ID: 25305150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Single-Step Transepithelial Photorefractive Keratectomy With or Without Mitomycin C in Mild to Moderate Myopia.
    Adib-Moghaddam S; Soleyman-Jahi S; Tefagh G; Tofighi S; Grentzelos MA; Kymionis GD
    J Refract Surg; 2018 Jun; 34(6):400-407. PubMed ID: 29889293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological effects of mitomycin C on late corneal haze stromal fibrosis following PRK.
    Carlos de Oliveira R; Wilson SE
    Exp Eye Res; 2020 Nov; 200():108218. PubMed ID: 32905844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the prophylactic use of mitomycin-C to inhibit haze formation after photorefractive keratectomy in high myopia: a prospective clinical study.
    Hashemi H; Taheri SM; Fotouhi A; Kheiltash A
    BMC Ophthalmol; 2004 Sep; 4():12. PubMed ID: 15363107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of standard (0.02%) and low dose (0.002%) mitomycin C in the prevention of corneal haze following surface ablation for myopia.
    Thornton I; Xu M; Krueger RR
    J Refract Surg; 2008 Jan; 24(1):S68-76. PubMed ID: 18269154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Retreatment after excimer laser photorefractive keratectomy].
    Xia X; Liu S; Huang P; Wu Z; Wang P; Xu H; Tan X; Mei E; Hu S
    Zhonghua Yan Ke Za Zhi; 1999 May; 35(3):203-6. PubMed ID: 11835807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.